Cannabis stocks on watch amid conflicting headlines on legalization in New York
- Wall Street closes rollercoaster week sharply lower
- Invesco (IVZ) Reportedly in Talks to Merge With State Street's (STT) Asset Management Business, Citi Sees More Cons than Pros
- FDA Votes "No" on Pfizer (PFE) Booster for 16+ Age Group, 2 Yes 16 No
- Jefferies Raises Price Targets on Alphabet (GOOGL) and Facebook (FB) as They Are Still Inexpensive Relative to Growth, Reiterates Snap (SNAP) as a Best Growth Idea
- Tesla (TSLA) Could Deliver 900K EV Units This Year and 1.3M in 2022 - Wedbush
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Cannabis stocks on watch amid conflicting headlines on legalization in New York. Some headlines suggest a deal is near, while others suggest an "impasse".
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AEye (LIDR) resumes after volatility halt, last up 57%
- Canopy Growth Announces Results of Annual General and Special Shareholder Meeting
- Ginkgo Bioworks (DNA) Climbs 16% After Closing SPAC Merger
Create E-mail Alert Related CategoriesTrader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!